MyFinsight
Home
Blog
About
Contact
Download
Download image
Receipt from germfree
(see note 13f)
$6,720K
Proceeds from issuance of
loans payable
$6,060K
Proceeds from issuance of
shares due to exercise...
$2,556K
Grant received in
respect of third party
$774K
Investment in long-term
deposits
-$500K
Proceeds from issuance of
convertible loans
$75K
Cash acquired from
acquisition of octomera (see...
$139K
Net change in cash
and cash...
-$752K
Net cash provided by
financing activities
$15,959K
Net cash used in
investing activities
$365K
Canceled cashflow
$226K
Canceled cashflow
$274K
Net change in cash
and cash...
-$752K
Canceled cashflow
$16,324K
Impairment expenses (see
note 2)
$18,338K
Loss from
extinguishment in connection...
-$5,422K
Convertible loans induced
conversion expenses
$4,304K
Stock-based compensation
$3,194K
Effect of exchange
differences on...
$2,447K
Prepaid expenses, other
accounts receivable
-$2,262K
Depreciation and
amortization expenses
$2,086K
Credit loss net related
to obi, korea and...
$2,049K
Net changes in
operating leases
-$1,588K
Interest expense accrued
on loans and...
-$1,538K
Employee and related
payables
$1,300K
Accounts receivable
-$130K
Other assets
-$43K
Inventory
-$34K
Share in loss of
associated companies, net
-$8K
Repayment of short and
long-term debt
$226K
Purchase of property,
plants and equipment
$263K
Impact to cash
resulting from...
$11K
Net cash used in
operating activities
-$17,076K
Canceled cashflow
$44,743K
Net loss
-$49,013K
Change in contingent
consideration
-$4,643K
Loss (gain) from
deconsolidation of obi, korea and...
$4,480K
Capital gain, net
$1,580K
Accounts payable
-$1,279K
Accrued expenses and
other payable
-$820K
Deferred taxes, net
$2K
Related parties, net
$2K
Back
Back
Cash Flow
source: myfinsight.com
Orgenesis Inc. (ORGS)
Orgenesis Inc. (ORGS)